Literature DB >> 10776796

Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates.

P Kraiczy1, K P Hunfeld, S Breitner-Ruddock, R Würzner, G Acker, V Brade.   

Abstract

A growth inhibition assay (GIA) and an immunofluorescence test detecting deposited complement components C6 and C9 were compared for their ability to classify Borrelia isolates with respect to their resistance to non-immune human serum (NHS). In both assays a total of 34 Borrelia isolates of all three human pathogenic genospecies were tested. Interestingly, 95% of the serum-sensitive or intermediate serum-sensitive isolates belonged to the genospecies B. burgdorferi s. s. and B. garinii, whereas most B. afzelii isolates (83%) proved serum-resistant. Consequently, a strong correlation between the assignment of the isolates to the different genospecies and their degree of serum sensitivity was seen. These findings were supported strongly by the quantitative analysis of the deposited complement components and the location of the terminal complement complex on the bacterial surface as detected by means of immunoelectron microscopy. The GIA displayed an obvious lack of sensitivity to slow growing isolates, whereas the IFA allowed classification of all Borrelia isolates. Discrimination between serum-sensitive and serum-resistant isolates in the IFA was the most specific provided that the detection of C6 and C9 was incorporated into the final classification of isolates. Accordingly, both assays, turned out to be effective and reliable tools for the investigation of borrelial serum sensitivity. The IFA, however, is regarded as superior to the GIA owing to the obvious ease of performance and its rapid capability for the classification of even very slow growing isolates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10776796     DOI: 10.1016/S0171-2985(00)80094-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  30 in total

1.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

2.  Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes.

Authors:  Brian Stevenson; Nazira El-Hage; Melissa A Hines; Jennifer C Miller; Kelly Babb
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii.

Authors:  Reinhard Wallich; Joseph Pattathu; Veronique Kitiratschky; Christiane Brenner; Peter F Zipfel; Volker Brade; Markus M Simon; Peter Kraiczy
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.

Authors:  P Kraiczy; J Weigand; T A Wichelhaus; P Heisig; H Backes; V Schäfer; G Acker; V Brade; K P Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.

Authors:  Nathalie D van Burgel; Peter Kraiczy; Tim J Schuijt; Peter F Zipfel; Alje P van Dam
Journal:  BMC Microbiol       Date:  2010-02-10       Impact factor: 3.605

6.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

7.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

Review 8.  Complement regulator-acquiring surface proteins of Borrelia burgdorferi: Structure, function and regulation of gene expression.

Authors:  Peter Kraiczy; Brian Stevenson
Journal:  Ticks Tick Borne Dis       Date:  2012-11-10       Impact factor: 3.744

9.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen.

Authors:  Annekatrin Seling; Corinna Siegel; Volker Fingerle; Brandon L Jutras; Catherine A Brissette; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Brian Stevenson; Peter Kraiczy
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.